Northwest Biotherapeutics, Inc. (NWBO)
USD 0.27
(1.89%)
USD 0.27
(1.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.93 Million | 1.68 Million | 1 Million | 1.29 Million | 2.41 Million | 412 Thousand |
| Cost of Revenue | 27.73 Million | 1.54 Million | 20.3 Million | 33.63 Million | 14.1 Million | 18.15 Million |
| Gross Profit | -25.79 Million | 135 Thousand | -19.3 Million | -32.34 Million | -11.69 Million | -17.74 Million |
| Operating Expenses | 57.44 Million | 68.86 Million | 53.7 Million | 87.89 Million | 29.87 Million | 45.16 Million |
| Selling, General and Administrative Expenses | 29.71 Million | 33.35 Million | 33.39 Million | 54.25 Million | 16.28 Million | 27.01 Million |
| Research and Development Expenses | 27.73 Million | 35.51 Million | 20.3 Million | 33.63 Million | 13.59 Million | 18.15 Million |
| Other Expenses | - | 33 Thousand | -647 Thousand | - | - | - |
| Cost and Expenses | 57.44 Million | 68.86 Million | 53.7 Million | 87.89 Million | 29.87 Million | 45.16 Million |
| Operating Income | -55.5 Million | -67.18 Million | -52.7 Million | -86.6 Million | -27.46 Million | -41.48 Million |
| Interest Expense | 5.24 Million | 6.06 Million | 5.01 Million | 8.54 Million | 2.97 Million | 9.87 Million |
| Income Tax Expense | - | 31.81 Million | 4.36 Million | 8.54 Million | 3.27 Million | 15.55 Million |
| Earnings before Tax | -62.59 Million | -105.03 Million | 179.12 Million | -529.82 Million | -20.29 Million | -35.79 Million |
| Net Income | -62.59 Million | -136.84 Million | 179.12 Million | -538.36 Million | -23.57 Million | -35.79 Million |
| Earnings Per Share Basic | -0.06 | -0.13 | 0.21 | -0.74 | -0.04 | -0.08 |
| Earnings Per Share Diluted | -0.06 | -0.13 | -0.06 | -0.74 | -0.04 | -0.08 |
| Weighted Average Shares Outstanding | 1.11 Billion | 1.01 Billion | 873.51 Million | 725.12 Million | 564.18 Million | 440.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.11 Billion | 1.01 Billion | 1 Billion | 725.12 Million | 564.18 Million | 440.01 Million |
| Gross Margin | -13.35 | 0.08 | -19.21 | -25.05 | -4.85 | -43.06 |
| EBIT Margin | -28.64 | -39.01 | -52.50 | -66.75 | -11.40 | -105.50 |
| Profit Margin | -32.40 | -81.31 | 178.23 | -417.01 | -9.78 | -86.88 |
| EBITDA | -55.33 Million | -97.41 Million | 184.72 Million | -520.85 Million | -17.81 Million | -24.62 Million |
| Earnings Before Tax Margin | -28.73 | -39.92 | -52.44 | -67.08 | -11.40 | -100.68 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 510 Thousand | 284 Thousand | 1.93 Million | 445 Thousand | 406 Thousand | 201 Thousand |
| Cost of Revenue | 516 Thousand | 505 Thousand | 1.73 Million | 421 Thousand | 489 Thousand | 421 Thousand |
| Gross Profit | -6000.00 | -221 Thousand | 199 Thousand | 24 Thousand | -83 Thousand | -220 Thousand |
| Operating Expenses | 17.45 Million | 15.52 Million | 55.7 Million | 15.16 Million | 14.23 Million | 13.77 Million |
| Selling, General and Administrative Expenses | 9.16 Million | 7.58 Million | - | 7.71 Million | 7.03 Million | 7.56 Million |
| Research and Development Expenses | 8.29 Million | 7.94 Million | - | 7.45 Million | 7.2 Million | 6.21 Million |
| Other Expenses | -174 Thousand | 1.66 Million | -78 Thousand | -47 Thousand | - | 99 Thousand |
| Cost and Expenses | 17.97 Million | 16.02 Million | 57.44 Million | 15.58 Million | 14.23 Million | 13.77 Million |
| Operating Income | -17.46 Million | -15.74 Million | -55.5 Million | -15.14 Million | -13.82 Million | -13.57 Million |
| Interest Expense | 1.68 Million | 1.51 Million | 5.52 Million | 1.24 Million | -1.67 Million | 1.3 Million |
| Income Tax Expense | - | 461.72 Thousand | 1.56 Million | -22 Thousand | -489 Thousand | 1.4 Million |
| Earnings before Tax | -17.86 Million | -18.31 Million | -62.59 Million | -18.91 Million | -19.09 Million | -14.44 Million |
| Net Income | -17.86 Million | -18.31 Million | -62.59 Million | -18.91 Million | -19.09 Million | -14.44 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | - | -0.02 | -0.02 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.02 | - | -0.02 | -0.02 | -0.01 |
| Weighted Average Shares Outstanding | 1.21 Billion | 1.18 Billion | 1.11 Billion | 1.15 Billion | 1.13 Billion | 1.1 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.21 Billion | 1.18 Billion | 1.11 Billion | 1.15 Billion | 1.13 Billion | 1.1 Billion |
| Gross Margin | -0.01 | -0.78 | 0.10 | 0.05 | -0.20 | -1.09 |
| EBIT Margin | -33.23 | -53.66 | - | -33.08 | -34.05 | -64.96 |
| Profit Margin | -35.04 | -64.48 | -32.40 | -42.51 | -47.04 | -71.88 |
| EBITDA | -16.94 Million | -15.23 Million | - | -14.72 Million | -13.82 Million | -13.05 Million |
| Earnings Before Tax Margin | -34.24 | -55.44 | -28.73 | -34.03 | -34.05 | -67.55 |
002942
MYCR
0HI3
1816
IMTX
GEKTERNA